Ionis Pharmaceuticals Inc. Stock
Ionis Pharmaceuticals Inc. gained 0.830% compared to yesterday.
The stock is one of the favorites of our community with 53 Buy predictions and 1 Sell predictions.
With a target price of 77 € there is a slightly positive potential of 17.56% for Ionis Pharmaceuticals Inc. compared to the current price of 65.5 €.
Our community identified positive and negative aspects for Ionis Pharmaceuticals Inc. stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Ionis Pharmaceuticals Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Ionis Pharmaceuticals Inc. in the next few years
Pros
?
B****
?
S********** s********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ionis Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ionis Pharmaceuticals Inc. | 0.830% | 6.562% | -4.918% | 132.915% | -4.414% | 96.998% | 69.431% |
| United Therapeutics | 1.480% | 11.672% | 20.347% | 79.930% | 20.009% | 155.378% | 258.601% |
| Novocure Ltd | 0.710% | -5.490% | -18.320% | -42.790% | -16.771% | -82.993% | -91.633% |
| Emergent Biosolutions Inc. | 1.450% | 1.214% | 4.095% | 59.324% | -31.011% | -24.927% | -90.984% |
Comments
Ionis Pharmaceuticals (IONS) had its price target raised by Barclays PLC from $95.00 to $106.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (IONS) had its price target raised by Needham & Company LLC from $103.00 to $105.00. They now have a "buy" rating on the stock.
Show more
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (IONS) had its price target raised by HC Wainwright from $110.00 to $120.00. They now have a "buy" rating on the stock.
Show more
Ratings data for IONS provided by MarketBeat